Confidential Addiction Treatment Admissions Process: Step-by-Step at Regal Recovery

Introduction: Why Privacy Fears Keep People from Getting Help

According to SAMHSA’s 2024 National Survey on Drug Use and Health, 80% of people who needed treatment for a substance use disorder in 2024 did not get treatment. That figure represents millions of people. While cost and access play a role, one of the most powerful and least-discussed drivers of that gap is fear: fear that an employer will find out, that a colleague will hear about it, that a family member will be told, or that a legal record will somehow surface.

That anxiety is real and worth taking seriously. Many people never make the first call to a treatment center because they imagine that simply reaching out will set off a chain of disclosures they cannot control. This article exists to dismantle that fear, not with vague reassurances, but with specifics. It walks through every step of the admissions process at Regal Recovery Alliance and shows exactly what happens at each stage, who sees what, and why.

Two layers of federal protection sit underneath everything described here: HIPAA and 42 CFR Part 2. As of February 16, 2026, civil enforcement of 42 CFR Part 2 is now active, making these protections more enforceable than they have ever been. Regal Recovery Alliance is a unified network of five accredited residential facilities across Los Angeles County, operating under a single standard of clinical excellence and a deep commitment to patient confidentiality. By the end of this article, the unknown will be known, and fear of the process should no longer stand between any reader and the care they need.

The Legal Foundation: Two Layers of Federal Protection

Addiction treatment is protected by two distinct federal frameworks that work together to create a stronger shield than either provides alone. The first is HIPAA, enacted in 1996, which governs Protected Health Information across virtually all healthcare settings. The second is 42 CFR Part 2, a regulation written specifically for substance use disorder (SUD) records that goes further than HIPAA in several critical ways.

The most striking protection under 42 CFR Part 2 is non-confirmation. A treatment program cannot even confirm or deny that a person is a patient without written consent. Staff cannot verify someone’s presence to a curious employer, a journalist, a family member, or anyone else who calls to ask. In addition, SUD records cannot be used in legal proceedings against patients without written consent or a qualifying court order.

Under HIPAA, Protected Health Information (PHI) includes a person’s name, address, Social Security number, diagnosis, prognosis, treatment details, dates of service, and any information that could identify the patient. Violations of these frameworks are federal offenses, carrying civil monetary penalties and, for knowing violations, criminal penalties that can include imprisonment.

Importantly, consent forms are not permanent. They are revocable at any time, either in writing or orally, and a revocation must be immediately communicated to the treatment team. The patient remains in control of their own information at every point.

What Changed in February 2026: The OCR Civil Enforcement Update

On February 16, 2026, the HHS Office for Civil Rights (OCR) began actively enforcing 42 CFR Part 2 with civil penalties aligned with HIPAA enforcement. This marks the first time civil enforcement mechanisms have been available to protect the confidentiality of SUD patient records.

The change traces back to the 2024 HHS Final Rule, which took effect in April 2024 with a compliance deadline of February 16, 2026. The rule updated 42 CFR Part 2 to align more closely with HIPAA while preserving the heightened protections that SUD records require. One practical simplification is the “single prior consent” provision: a single written consent form can now cover all future treatment, payment, and healthcare operations disclosures, reducing paperwork without weakening protection.

Covered entities were also required to update their Notices of Privacy Practices by February 16, 2026, to include a separate statement about limits on the use or disclosure of Part 2 records in legal proceedings. For patients, this matters because these protections are no longer just words on paper; they now carry real federal consequences. Regal’s intake documentation and privacy notices reflect the February 2026 compliance standards, ensuring its admissions process is fully current.

Step 1: The First Call, What Happens and Who Hears It

Regal Recovery Alliance operates a confidential admissions line available 24 hours a day, seven days a week, at (424) 235-8288.

The first call is a brief, compassionate conversation with an admissions specialist. It is not a formal intake, not a legal commitment, and not a recorded disclosure. The specialist may ask general questions about substance use concerns, the caller’s current living situation, whether they have insurance, and what level of care might be appropriate. The purpose is to help, not to judge.

Equally important is what does not happen. No employer is notified. No record is created in any external database. No insurance claim is filed. A brief inquiry does not create a patient record and does not trigger any disclosure obligations whatsoever.

Regal’s admissions team is trained to treat every caller with dignity and discretion. Confidentiality is a cultural commitment, not merely a legal checkbox. For those who prefer to write before speaking with anyone, email contact is also available at [email protected].

Step 2: Insurance Verification, The Employer Notification Myth Debunked

One of the most common and underaddressed fears is this: “If I check my insurance benefits, will my employer find out?”

The answer is clear. Checking insurance coverage for addiction treatment does not notify an employer or insurance company that an inquiry was made. It is simply a benefits verification. Regal’s admissions team contacts the insurer on the patient’s behalf to confirm what benefits are available, what the deductible and out-of-pocket costs are, and whether prior authorization is needed.

When claims are eventually processed, insurers typically receive only diagnosis codes, service types, dates of service, and provider information. Detailed therapy notes and personal disclosures made during sessions are not shared. There is also a firewall between employers and insurers: even when an employer provides the patient’s health plan, HIPAA prohibits the insurer from sharing individual patient treatment details with that employer.

Regal accepts most major PPO insurance plans, including Anthem Blue Cross, Aetna, United Healthcare, Cigna, Kaiser Permanente, Highmark, Horizon Blue Cross, NYSHIP, GEHA, UMR, and others. For those who prefer not to use insurance at all, cash pay options are available. In every case, Regal offers confidential insurance verification, and results are shared only with the patient.

Step 3: Pre-Admission Screening, A Conversation, Not an Interrogation

The pre-admission screening is a structured but conversational assessment, usually conducted by phone with a licensed clinician or trained admissions professional. It typically gathers information across four categories, each with a clear clinical purpose:

• Substance use history: to determine the appropriate level of care and any detox needs
• Medical history: to identify withdrawal risks and medication considerations
• Mental health history: to screen for co-occurring disorders such as depression, anxiety, PTSD, or bipolar disorder
• Current living situation: to assess safety and available support

Every question serves a clinical purpose. None of it is surveillance, judgment, or reporting. This information is used to match the patient to the right ASAM level of care within Regal’s network, spanning Levels 3.1 through 3.7, and to begin building an individualized treatment plan.

Access is strictly limited to the clinical and medical team directly involved in the patient’s care. It is not visible to administrative staff, family members, employers, or law enforcement. Under 42 CFR Part 2, protections apply from the moment a person seeks treatment, not just at formal admission. No information collected during screening will be shared without a signed, written consent form.

Step 4: Formal Intake Assessment, What Patients Are Asked and Why It Stays Private

The formal intake assessment is a comprehensive, in-person evaluation conducted upon arrival, typically lasting one to three hours. The team uses this in-depth assessment to develop the treatment plan. It generally includes:

• Medical evaluation: vital signs, physical exam, and lab work to assess withdrawal risk and overall health
• Psychological evaluation: mental health screening, trauma history, mood, and cognitive assessment
• Substance use history: types of substances, frequency, duration, last use, and prior treatment
• Social history: family, employment, and legal history, used solely for treatment planning

The legal history question deserves direct attention. Information about past legal issues disclosed during intake is protected under 42 CFR Part 2 and cannot be used against the patient in legal proceedings without written consent or a court order.

At the moment of admission, federal law requires the program to inform the patient in writing, in plain language, of their confidentiality rights. Regal fulfills this requirement at intake. Patients are also asked to sign consent forms specifying exactly who may receive information and for what purpose; those consents can be revoked at any time. Under the 2024/2026 rule, a single prior written consent can now cover all future treatment, payment, and healthcare operations disclosures. Regal’s 1:1.5 staff-to-patient ratio reflects this attentiveness: the intake is thorough because the plan that follows is genuinely personalized.

Step 5: The First Day of Care, Privacy in Practice

The first day at a Regal facility includes orientation to the residential environment, meeting the clinical and medical team, initial medical monitoring (especially important for detox patients), and the beginning of the individualized treatment plan.

Regal’s facilities are designed as discreet residential homes that blend into their neighborhoods. There is no visible signage and no institutional markers identifying the location as a treatment center. Inside, the environment offers amenities such as private in-house chefs or catering and weekly supervised outings, all designed to promote healing, safety, and dignity.

Non-confirmation protection becomes tangible here. If anyone calls the facility asking whether a specific person is a patient, staff are legally prohibited from confirming or denying that the person is present. Under 42 CFR Part 2, this applies to employers, family members, law enforcement, and anyone not named on a signed consent form.

The treatment plan developed during intake begins to take shape with the patient as an active participant and is continuously evaluated and adjusted. Because Regal’s network covers five ASAM levels of care (3.1, 3.2, 3.3, 3.5, and 3.7), patients can transition between care intensities without changing providers, ensuring continuity of care alongside continuity of confidentiality. With 24/7 medical supervision in place from day one, patients are never alone in managing withdrawal or early recovery.

Confidentiality for Employed Patients: FMLA, ADA, and EEOC Protections

Employed patients, particularly professionals, often carry a compounded fear: not just personal exposure, but professional consequences. Three federal protections address this directly.

The Family and Medical Leave Act (FMLA) allows eligible employees up to 12 weeks of unpaid, job-protected leave per year for substance abuse treatment, and employees are not required to disclose the specific medical reason for the leave. The Americans with Disabilities Act (ADA) prohibits employers from firing, demoting, or refusing to hire someone based solely on participation in a drug rehabilitation program or a past substance use disorder. EEOC guidelines prevent employers from legally asking job applicants about addiction history or whether they have attended rehab.

Licensed professionals face a sharper version of this fear. Up to 15% of physicians experience SUDs, but nearly 75% are referred to treatment from external sources rather than self-reporting, a pattern driven largely by fear. Yet the outcomes for proactive treatment are striking: 78% of doctors who completed treatment remained drug-free after five years, and 71% retained their license and employment.

Regal’s admissions team is experienced in helping professionals navigate leave-of-absence logistics, workplace communication strategies, and the intersection of treatment confidentiality with licensing concerns. None of the information disclosed during treatment is reported to licensing boards, employers, or professional associations without the patient’s written consent.

Special Considerations: Public Figures, High-Profile Individuals, and Remote Admissions

Public figures, executives, and media personalities face an additional layer of concern beyond employer exposure: media scrutiny, reputational risk, and public visibility. Regal’s residential model is well suited to these realities, with discreet homes that blend into neighborhoods, no institutional signage, and a culture of absolute discretion among staff.

The non-confirmation protection under 42 CFR Part 2 is especially powerful in these cases. No staff member can confirm or deny a person’s presence, regardless of who is asking or why.

Telehealth and digital platforms have also expanded confidential access to care. Initial assessments and pre-admission consultations can often be conducted remotely, allowing individuals to begin the process without physically entering a facility. Because Regal accepts patients from across the United States, traveling out of state can itself function as a privacy strategy, removing the patient from their immediate professional and social environment. Research has associated out-of-state treatment with 40 to 60% lower relapse rates, making geographic distance both a privacy benefit and a clinical one.

What Regal Collects, What Regal Protects: A Quick-Reference Summary

Stage	What Is Collected	Who Can Access It	What Protects It
First call	General inquiry information	Admissions specialist only; no external disclosure	42 CFR Part 2 from first contact
Insurance verification	Benefits eligibility data	Regal and the insurer, for billing only	HIPAA; employer cannot access treatment details
Pre-admission screening	Substance use, medical, mental health history	Direct care team only	HIPAA and 42 CFR Part 2
Formal intake	Comprehensive medical, psychological, social history	Direct care team only	HIPAA and 42 CFR Part 2; written notice of rights provided
Ongoing treatment	Therapy notes, medication and progress records	Direct care team only	Both frameworks; not shared in detail with insurers or employers

Across every stage, consent forms remain specific, limited, and revocable at any time. The patient controls what is shared, and with whom, throughout the entire treatment episode.

Conclusion: Confidentiality Is Not a Promise, It Is Federal Law

The fear of exposure does not have to stand between someone and addiction treatment, and under current federal law, it legally need not. Two layers of federal protection, HIPAA and 42 CFR Part 2, work together to safeguard patient records, and the February 2026 OCR civil enforcement update means those protections now carry real, enforceable consequences for violations.

Consider again that 80% of people who needed treatment in 2024 did not receive it. Confidentiality protections exist precisely because Congress and HHS recognized that fear of disclosure is a structural barrier to care. Regal Recovery Alliance’s admissions process, from the first call to the first day of care, is designed to be transparent, dignified, and fully compliant with the most current federal privacy standards.

Seeking treatment proactively, under the protection of federal law, leads to better outcomes clinically, professionally, and personally.

Take the First Confidential Step with Regal Recovery Alliance

Anyone ready to take that step can call or text Regal’s 24/7 confidential admissions line at (424) 235-8288, or email [email protected]. The first call is confidential, carries no obligation, and does not create a patient record or trigger any disclosure.

For those unsure what their insurance covers, Regal will verify benefits confidentially, at no cost, and with no employer notification. The admissions team is available around the clock and experienced in helping individuals from all backgrounds, including professionals, public figures, and out-of-state patients, navigate the process with complete discretion.

Regal Recovery Alliance operates five accredited residential facilities across Los Angeles County, covering five ASAM levels of care, with a 1:1.5 staff-to-patient ratio and evidence-based treatment led by Medical Director Dr. Julio Meza, MD. Patients are in control of this process every step of the way, and Regal is here to support each one.